THBD and cancer: Furthermore, numerous clinical factors—such as age, cancer stage at diagnosis, comorbidities, treatment strategies, and therapeutic responses—can have a more substantial effect on survival outcomes, potentially obscuring any connection between thrombomodulin levels and overall survival.